Date Filed | Type | Description |
11/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/03/2016 |
4
| DP VI Associates, L.P. (10% Owner) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Unknown transaction of 1,657 shares
@ $28.35, valued at
$47k
|
|
11/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/03/2016 |
4
| Domain Partners VI, L.P. (10% Owner) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Unknown transaction of 285,679 shares
@ $28.35, valued at
$8.1M
|
|
11/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/03/2016 |
4
| Brosgart Carol L (Director) has filed a Form 4 on Tobira Therapeutics, Inc. |
11/03/2016 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on Tobira Therapeutics, Inc. |
11/03/2016 |
4
| Cooper Jeffrey H (Director) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Disposed/sold 13,539 options to buy
@ $8.13, valued at
$110.1k
Disposed/sold 15,500 options to buy
@ $16.52, valued at
$256.1k
Disposed/sold 17,778 options to buy
@ $7.91, valued at
$140.6k
|
|
11/03/2016 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Unknown transaction of 243,726 shares
@ $0 Disposed/sold 4,332 options to buy
@ $2.96, valued at
$12.8k
Disposed/sold 15,500 options to buy
@ $16.52, valued at
$256.1k
Disposed/sold 17,778 options to buy
@ $7.91, valued at
$140.6k
|
|
11/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/03/2016 |
4
| Jenkins Helen (COO) has filed a Form 4 on Tobira Therapeutics, Inc. |
11/03/2016 |
4
| Peetz Christopher (CFO) has filed a Form 4 on Tobira Therapeutics, Inc. |
11/03/2016 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on Tobira Therapeutics, Inc. |
11/03/2016 |
4
| Fischer Laurent (CEO) has filed a Form 4 on Tobira Therapeutics, Inc. |
11/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/30/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/29/2016 |
3
| Allergan plc (10% Owner) has filed a Form 3 on Tobira Therapeutics, Inc. |
09/28/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/22/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
07/13/2016 |
4
| Novo A/S (10% Owner) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Sold 20,431 shares
@ $12.1923, valued at
$249.1k
Sold 8,752 shares
@ $12.1198, valued at
$106.1k
Sold 29,884 shares
@ $11.8774, valued at
$354.9k
|
|
07/07/2016 |
4
| Novo A/S (10% Owner) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Sold 10,400 shares
@ $12.5682, valued at
$130.7k
Sold 59,850 shares
@ $12.2017, valued at
$730.3k
Sold 21,869 shares
@ $12.033, valued at
$263.1k
|
|
06/30/2016 |
4
| Novo A/S (10% Owner) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Sold 20,883 shares
@ $13.7744, valued at
$287.7k
Sold 2,730 shares
@ $14.2765, valued at
$39k
Sold 16,068 shares
@ $12.6305, valued at
$202.9k
Sold 27,133 shares
@ $12.5813, valued at
$341.4k
|
|
06/07/2016 |
4
| Novo A/S (10% Owner) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Sold 187,500 shares
@ $10.3675, valued at
$1.9M
|
|
03/04/2016 |
4
| Novo A/S (10% Owner) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Sold 110,000 shares
@ $6.9184, valued at
$761k
Sold 25,000 shares
@ $6.8558, valued at
$171.4k
Sold 55,000 shares
@ $6.5394, valued at
$359.7k
|
|
01/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/14/2016 |
4
| Peetz Christopher (CFO) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Granted 101,000 options to buy
@ $7.91, valued at
$798.9k
|
|
01/14/2016 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Granted 101,000 options to buy
@ $7.91, valued at
$798.9k
|
|
|